Home
AVXL
AVXL News

Latest Anavex Life Sciences Corp. (AVXL) News on April 24, 2025

Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

GlobeNewswire

13 hours ago

Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ...

GuruFocus.com

2 days ago

Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ...

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

GlobeNewswire

3 days ago

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

High Growth Tech Stocks To Watch In The US Market

Simply Wall St.

16 days ago

High Growth Tech Stocks To Watch In The US Market

AD/PD 2025: Long-term data shows Anavex’s Blarcamesine benefits in early Alzheimer’s

Clinical Trials Arena

16 days ago

AD/PD 2025: Long-term data shows Anavex’s Blarcamesine benefits in early Alzheimer’s

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years

Benzinga

16 days ago

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

GlobeNewswire

18 days ago

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

24 days ago

Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

2 months ago

Exploring 3 High Growth Tech Stocks In The US Market

Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future

Simply Wall St.

2 months ago

Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

GlobeNewswire

2 months ago

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

Associated Press Finance

2 months ago

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

GlobeNewswire

2 months ago

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

GlobeNewswire

3 months ago

Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’

Insider Monkey

3 months ago

Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

GlobeNewswire

3 months ago

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why

Zacks

3 months ago

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why

Best Momentum Stocks to Buy for January 21st

Zacks

3 months ago

Best Momentum Stocks to Buy for January 21st

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

GlobeNewswire

3 months ago

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

GlobeNewswire

3 months ago

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

4 months ago

Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?

All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy

Zacks

4 months ago

All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy

Anavex price target raised to $42 from $40 at H.C. Wainwright

TipRanks

4 months ago

Anavex price target raised to $42 from $40 at H.C. Wainwright

Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability

TipRanks

4 months ago

Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

Simply Wall St.

4 months ago

We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn

Anavex Life Sciences Corp (AVXL) Q4 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com

4 months ago

Anavex Life Sciences Corp (AVXL) Q4 2024 Earnings Call Highlights: Strong Cash Position and ...

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Anavex Life Sciences Corp Earnings Call

MT Newswires

4 months ago

Anavex Says it Gets EMA Filing Acceptance for Blarcamesine to Treat Alzheimer's Disease

Associated Press Finance

4 months ago

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease

GlobeNewswire

4 months ago

Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease

Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024

GlobeNewswire

4 months ago

Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

GlobeNewswire

4 months ago

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024

GlobeNewswire

5 months ago

Anavex Life Sciences to Present at the 7th Annual Evercore ISI HealthCONx Conference 2024

MT Newswires

5 months ago

Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell

Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA

GlobeNewswire

5 months ago

Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA

Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal

GlobeNewswire

5 months ago

Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024

GlobeNewswire

6 months ago

Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

GlobeNewswire

6 months ago

Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

GuruFocus.com

6 months ago

Anavex Life Sciences Corp (AVXL) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?

Simply Wall St.

7 months ago

Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

GlobeNewswire

8 months ago

Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024

Associated Press Finance

9 months ago

Anavex Life Sciences: Fiscal Q3 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update

GlobeNewswire

9 months ago

Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024

GlobeNewswire

9 months ago

Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024

Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference

GlobeNewswire

9 months ago

Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference

MT Newswires

9 months ago

Anavex Life Sciences Files $150 Million Shelf

Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%

Benzinga

9 months ago

Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39%

Anavex seek EMA approval despite shaky pivotal Alzheimer’s trial data

Clinical Trials Arena

9 months ago

Anavex seek EMA approval despite shaky pivotal Alzheimer’s trial data

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

GlobeNewswire

9 months ago

Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion

Zacks

9 months ago

Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion

HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails

Zacks

9 months ago

HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails

Institutions own 38% of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares but individual investors control 59% of the company

Simply Wall St.

10 months ago

Institutions own 38% of Anavex Life Sciences Corp. (NASDAQ:AVXL) shares but individual investors control 59% of the company

Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire

10 months ago

Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

10 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

10 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

10 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

10 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

10 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

10 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

10 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

10 months ago

Best Date Night Fragrance in 2024

MT Newswires

a year ago

Sector Update: Health Care Stocks Slightly Higher Late Afternoon

MT Newswires

a year ago

Anavex Life Sciences Expands Leadership Team; Shares Rise

Anavex Life Sciences Announces Expansion of Leadership Team

GlobeNewswire

a year ago

Anavex Life Sciences Announces Expansion of Leadership Team

Anavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

a year ago

Anavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth Plans

Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a year ago

Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript

Insider Monkey

a year ago

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call Transcript

Associated Press Finance

a year ago

Anavex Life Sciences: Fiscal Q2 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

GlobeNewswire

a year ago

Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

GlobeNewswire

a year ago

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

GlobeNewswire

a year ago

Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

12 $10 Stocks That Will Triple

Insider Monkey

a year ago

12 $10 Stocks That Will Triple

Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference

GlobeNewswire

a year ago

Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

Associated Press Finance

a year ago

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot

Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update

GlobeNewswire

a year ago

Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update

Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024

GlobeNewswire

a year ago

Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024

Univest Financial (NASDAQ:UVSP) Has Affirmed Its Dividend Of $0.21

Simply Wall St.

a year ago

Univest Financial (NASDAQ:UVSP) Has Affirmed Its Dividend Of $0.21

Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal

Zacks

a year ago

Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal

GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance

Zacks

a year ago

GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance

Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to Trade

Zacks

a year ago

Wall Street Analysts Believe Anavex Life Sciences (AVXL) Could Rally 530.68%: Here's is How to Trade

Coeur Mining (NYSE:CDE) investors are sitting on a loss of 70% if they invested three years ago

Simply Wall St.

a year ago

Coeur Mining (NYSE:CDE) investors are sitting on a loss of 70% if they invested three years ago

TXO Partners' (NYSE:TXO) Returns On Capital Are Heading Higher

Simply Wall St.

a year ago

TXO Partners' (NYSE:TXO) Returns On Capital Are Heading Higher

i3 Verticals Announces Earnings Release and Conference Call Dates for First Quarter of Fiscal 2024

Business Wire

a year ago

i3 Verticals Announces Earnings Release and Conference Call Dates for First Quarter of Fiscal 2024

2024 Looks Promising for Eldorado Gold

GuruFocus.com

a year ago

2024 Looks Promising for Eldorado Gold

CENTERSPACE ANNOUNCES 2023 DIVIDEND ALLOCATIONS

PR Newswire

a year ago

CENTERSPACE ANNOUNCES 2023 DIVIDEND ALLOCATIONS

Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why

Zacks

a year ago

Anavex Life Sciences (AVXL) Upgraded to Strong Buy: Here's Why

Transcat, Inc. (TRNS) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Zacks

a year ago

Transcat, Inc. (TRNS) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans

GlobeNewswire

a year ago

Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans

Why (Most) EV Stocks Had a Phenomenal Day Today

Motley Fool

a year ago

Why (Most) EV Stocks Had a Phenomenal Day Today

Genco Highlights Steps the Company Is Taking to Drive Sustainable, Long-Term Shareholder Value

GlobeNewswire

a year ago

Genco Highlights Steps the Company Is Taking to Drive Sustainable, Long-Term Shareholder Value

Q3 Earnings Highlights: Zuora (NYSE:ZUO) Vs The Rest Of The Finance and HR Software Stocks

StockStory

a year ago

Q3 Earnings Highlights: Zuora (NYSE:ZUO) Vs The Rest Of The Finance and HR Software Stocks

All You Need to Know About 4D Molecular Therapeutics, Inc. (FDMT) Rating Upgrade to Strong Buy

Zacks

a year ago

All You Need to Know About 4D Molecular Therapeutics, Inc. (FDMT) Rating Upgrade to Strong Buy

Specialty Retail Stocks Q3 Recap: Benchmarking Tractor Supply (NASDAQ:TSCO)

StockStory

a year ago

Specialty Retail Stocks Q3 Recap: Benchmarking Tractor Supply (NASDAQ:TSCO)

CENTERSPACE ANNOUNCES FOURTH QUARTER 2023 EARNINGS RELEASE DATE

PR Newswire

a year ago

CENTERSPACE ANNOUNCES FOURTH QUARTER 2023 EARNINGS RELEASE DATE

Share on Social Networks: